OPEN END TURBO LONG - CARL ZEISS MEDITEC Stock

Certificat

IR75

AT0000A1JKP6

Market Closed - Wiener Boerse 11:25:00 2024-05-21 EDT
6.85 EUR -2.56% Intraday chart for OPEN END TURBO LONG - CARL ZEISS MEDITEC
Current month-7.81%
1 month-5.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 6.85 -2.56%
24-05-20 7.03 -0.14%
24-05-17 7.04 -1.68%
24-05-16 7.16 +0.70%
24-05-15 7.11 +0.28%

Delayed Quote Wiener Boerse

Last update May 21, 2024 at 11:25 am

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
Issuer Erste Group Bank
IR75
ISINAT0000A1JKP6
Date issued 2016-01-22
Strike 24.87
Maturity Unlimited
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 17.8
Lowest since issue 0.32

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
92.95 EUR
Average target price
105.5 EUR
Spread / Average Target
+13.54%
Consensus
  1. Stock Market
  2. Certificates
  3. IR75 Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW